BidaskClub upgraded shares of BioSpecifics Technologies (NASDAQ:BSTC) from a strong sell rating to a sell rating in a research note published on Saturday morning.
Several other research analysts have also weighed in on BSTC. HC Wainwright reiterated a buy rating and issued a $65.00 price objective on shares of BioSpecifics Technologies in a research note on Tuesday, March 13th. Zacks Investment Research upgraded shares of BioSpecifics Technologies from a hold rating to a buy rating and set a $47.00 price objective on the stock in a research note on Friday, March 16th.
BSTC stock opened at $43.13 on Friday. The firm has a market cap of $310.50, a P/E ratio of 25.37 and a beta of 1.55. BioSpecifics Technologies has a 12 month low of $38.05 and a 12 month high of $58.79.
COPYRIGHT VIOLATION WARNING: “BioSpecifics Technologies (BSTC) Stock Rating Upgraded by BidaskClub” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3298974/biospecifics-technologies-bstc-stock-rating-upgraded-by-bidaskclub.html.
BioSpecifics Technologies Company Profile
BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of Endo International plc (Endo), for injectable collagenase for marketed indications and indications in development.
Receive News & Ratings for BioSpecifics Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSpecifics Technologies and related companies with MarketBeat.com's FREE daily email newsletter.